Detalles de la búsqueda
1.
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
N Engl J Med
; 383(1): 35-48, 2020 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32579807
2.
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.
Am J Respir Crit Care Med
; 203(5): 553-564, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33252985
3.
A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD.
Respir Res
; 19(1): 38, 2018 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29506504
4.
The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults.
Pulm Pharmacol Ther
; 50: 11-18, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29544728
5.
Randomized dose-ranging study of a budesonide metered-dose inhaler by using co-suspension delivery technology in asthma.
Allergy Asthma Proc
; 39(5): 350-358, 2018 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30037361
6.
24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD.
Respir Res
; 18(1): 157, 2017 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28821260
7.
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res
; 18(1): 8, 2017 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28061907
8.
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD.
Respir Res
; 17(1): 109, 2016 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27586537
9.
Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res
; 18(1): 158, 2017 08 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28826397
10.
Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD.
Ther Adv Respir Dis
; 14: 1753466620916990, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32380894
11.
An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease.
J Aerosol Med Pulm Drug Deliv
; 32(1): 40-46, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30335559
12.
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6⯵g and 160/18/9.6⯵g using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol.
Respir Med
; 158: 59-66, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31605923
13.
Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD.
Int J Chron Obstruct Pulmon Dis
; 13: 1187-1194, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29695902
14.
Erratum: Erratum: Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study.
Chronic Obstr Pulm Dis
; 4(3): 258, 2017 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28853450
15.
A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD.
Respir Med
; 120: 16-24, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27817811
16.
Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study.
Chronic Obstr Pulm Dis
; 4(1): 21-33, 2016 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28848908
17.
A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD.
Respir Med
; 108(9): 1327-35, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25060541
18.
Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24].
Respir Med
; 129: 164, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28732826
Resultados
1 -
18
de 18
1
Próxima >
>>